CAPE TOWN, Feb 4: South Africa's Afrigen Biologics has used the publicly available sequence of Moderna Inc's (MRNA.O) mRNA COVID-19 vaccine to make its own version of the shot, which could be tested in humans before the end of this year, Afrigen's top executive said on Thursday.

SARLAHI, Jan 31: Students in Sarlahi will be vaccinated against COVID-19 from today. The schools will be open from today till February 4 to administer the second dose of COVID-19 vaccines to the students in the age group of 12 to 17 years.

DAMAULI, Jan 31: Children of Tanahun are to be inoculated with the second dose of Moderna vaccine against COVID-19. The second shot is to be administered to the children aged 12-17 who have earlier jabbed with the first dose.

Jan 27: Moderna Inc (MRNA.O) said on Wednesday it had started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically designed to target the Omicron coronavirus variant, a day after rival Pfizer Inc (PFE.N) launched a similar trial.

KATHMANDU, Jan 25: An additional four million doses of Moderna vaccine are arriving in Nepal from the United States. Of these, 1.6 million doses were delivered on Monday night and the remaining 2.34 million doses are being delivered to Nepal on Tuesday morning, according to the Logistics Management Section under the Department of Health Services(DHS).

Dec 17: Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday.

KATHMANDU, Dec 16: Germany provided more than 401 million doses of Moderna and Johnson & Johnson vaccines to Nepal on Thursday.

SIMKIOT, Dec 15: Children of the 12-17 age group are to be vaccinated against COVID-19 in Humla district. Moderna vaccines will be administered to 9,621 children of that age group.

KATHMANDU, Sec 9: More than 1.4 million doses of Moderna vaccine against the novel coronavirus are arriving in the country on Thursday.

Dec 7: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.

KATHMANDU, Dec 1: As many as 972,000 doses of Covishield vaccine from the Serum Institute of India are set to arrive in Nepal today.

KATHMANDU, Oct 3: State Minister for Health and Population, Umesh Shrestha has said that children below the age of 18 will be administered vaccines against COVID-19 right after Dashain.

CHICAGO, Sept 16: New data from Moderna Inc's (MRNA.O) large COVID-19 vaccine trial shows that the protection it offers wanes over time, supporting the case for booster doses, the company said in a news release on Wednesday.

TOKYO, Sept 1: Japan's Kanagawa prefecture said it has found another vial of Moderna Inc's (MRNA.O) COVID-19 vaccine suspected of containing a foreign substance and has put the rest of the lot on hold.

TOKYO, August 31: Japan's health minister said on Tuesday it was highly likely that foreign matter found in Moderna Inc (MRNA.O) COVID-19 vaccines in the southern prefecture of Okinawa were caused when needles were stuck into the vials.

August 26: Moderna Inc (MRNA.O) said on Wednesday it has withheld supply of about 1.63 million doses of its COVID-19 vaccine in Japan after a report of contamination of vials with particulate matter, which it suspects involves a production line in Spain.

August 10: The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.

August 5: Moderna Inc (MRNA.O) said on Thursday its COVID-19 shot was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial.

USA, May 26: Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the U.S.

FRANKFURT, Nov 22: Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

MASSACHUSETTS, Nov 17: Moderna Inc’s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations.